切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2013, Vol. 09 ›› Issue (05) : 589 -593. doi: 10.3877/cma.j.issn.1673-5250.2013.05.004

所属专题: 文献

论著

高强度聚焦超声治疗女性外阴上皮内非瘤样病变组织的雌、孕激素受体及生存素表达及意义
尹格平1,*,*(), 武爱芳1, 梁静1, 支圆圆1   
  1. 1. 250031 山东济南,济南军区总医院妇产科
  • 收稿日期:2013-06-21 修回日期:2013-08-27 出版日期:2013-10-01
  • 通信作者: 尹格平

Expression of Survivin, Estrogen and Progesterone Receptor in Focal Tissues Before and After Treatment by High Intensity Focused Ultrasound for Nonneoplasia Epithelial Disorders of Skin and Mucosa of Vulva

Ge-ping YIN1(), Ai-fang WU1, Jing LIANG1, Yuan-yuan ZHI1   

  1. 1. Department of Gynecology, Jinan Millitary General Hospital, Jinan 250031, Shandong Province, China
  • Received:2013-06-21 Revised:2013-08-27 Published:2013-10-01
  • Corresponding author: Ge-ping YIN
  • About author:
    (Corresponding author: YIN Ge-ping, Email: )
引用本文:

尹格平, 武爱芳, 梁静, 支圆圆. 高强度聚焦超声治疗女性外阴上皮内非瘤样病变组织的雌、孕激素受体及生存素表达及意义[J]. 中华妇幼临床医学杂志(电子版), 2013, 09(05): 589-593.

Ge-ping YIN, Ai-fang WU, Jing LIANG, Yuan-yuan ZHI. Expression of Survivin, Estrogen and Progesterone Receptor in Focal Tissues Before and After Treatment by High Intensity Focused Ultrasound for Nonneoplasia Epithelial Disorders of Skin and Mucosa of Vulva[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2013, 09(05): 589-593.

目的

探讨高强度聚焦超声(HIFU)治疗女性外阴上皮内非瘤样病变(NEDV)组织中雌激素受体(ER)、孕激素受体(PR)及生存素(survivin)的表达及意义。

方法

收集2009年1月至2011年9月在本院诊治,并经组织病理学标本检查证实为NEDV的患者86例为研究对象。其年龄为15~75岁,平均为(43.0±14.5)岁。对其按照NEDV组织病理学标准进行分类:鳞状上皮细胞增生型(SHV)为43例,硬化性苔癣型(LSV)为29例,硬化性苔癣合并鳞状上皮细胞增生型(LSCSH)为14例。采取HIFU治疗前,对86例患者的病灶标本进行组织活检,并随机采集30例患者的病灶周围正常皮肤组织进行活检;治疗6个月后复检。采用免疫组织化学法检测病变组织中ER,PR及survivin的表达水平。采取"外阴瘙痒评分法"、"外阴白色病变面积计算法"和"四度皮肤弹性评估法"判断HIFU治疗的客观疗效(本研究遵循的程序符合本院人体试验委员会所制定的伦理学标准,得到该委员会批准,征得受试对象本人的知情同意,并与之签署临床研究知情同意书)。

结果

86例患者于HIFU治疗结束后6个月时,①采用"外阴瘙痒法"进行疗效判断的有效率为100%,同时白色病变面积由(11.21±7.50) cm2缩小为(6.60±3.17) cm2,外阴瘙痒评分降低率与白色病变区面积缩小率与治疗前比较,差异均有统计学意义(P<0.01)。②ER,PR与survivin在SHV型,LSV型及LSCSH型的表达水平与治疗前比较,差异无统计学意义(P>0.05)。HIFU治疗前,ER,PR在正常外阴组织中的阳性表达率显著高于病变组织,survivin则显著降低,差异均有统计学意义(P<0.05)。③ER,PR在局部组织中的表达水平较治疗前明显增加,survivin则明显降低,差异均有统计学意义(P<0.05)。

结论

survivin在NEDV组织表达增高,而ER,PR表达降低,这可能与NEDV发病有关。HIFU治疗前、后,根据ER,PR及survivin在NEDV组织的表达情况,可判断疗效。

Objective

To investigate the expression levels and significance of estrogen receptor(ER), progesterone receptor (PR) and survivin in the focal tissues of non-neoplasia epithelial disorders of skin and mucosa of vulva(NEDV) before treatment and after 6 months of treatment by high intensity focused ultrasound(HIFU).

Methods

From January 2009 to September 2011, a total of 86 cases with NEDV, in an average age of (43.0±14.5) years old (15 to 75 years old), confirmed by biopsy pathology before treatment by HIFU, and 30 patients were randomly obtained the normal tissues nearby the focuses for control. According to histological classification of NEDV, 86 patients with NEDV were divided into three pathological types.Types of squamous hyperplasia(SHV)were 43 cases, lichen sclerosus(LSV)were 29 cases, and lichen sclerosus combined with squamous hyperplasia(LSCSH)were 14 cases.Immunohistochemical analysis for survivin, ER and PR expression were carried out on the tissue samples collected before treatment and after 6 months of treatment by HIFU. The methods of Vulvar Pruritus Score, Vulvar Leucoplakia Area Calculation and Vulvar Skin Elasticity were designed for objective evaluation of curative effect. Informed consent was obtained from all participants.

Results

After 6 months of treatment by HIFU, ① the curative rate of relieving-pruritus was 100%, and the average areas of vulvar leucoplakia of 86 patients with NEDV decreased from (11.21±7.50) cm2 to (6.60±3.17) cm2, and there were statistically more effective for Vulvar Pruritus Score and Vulvar Leucoplakia Area Calculation than those before treatment by HIFU(P<0.01). ②Expression levels of survivin, ER, and PR before treatment and after 6 months of treatment by HIFU, there had no statistical difference among the three pathological types: SHV, LSV and LSCSH(P>0.05), respectively. Positive rates of ER and PR expression before treatment and after 6 months of treatment by HIFU in normal vulvar tissues were much higher than those of focus tissues(P<0.05), but the survivin were much lower(P<0.05). ③Positive rates of ER and PR expression after 6 months of treatment by HIFU in focal tissues became much higher, as well as the surviving much lower than those before treatment by HIFU(P<0.05).

Conclusions

Expression levels increasing of survivin and decreasing of ER and PR could be the essential factors of pathogenesis for NEDV. Expression levels of survivin, ER and PR may play an important role in indicate the curative effect.

表1 研究组治疗前与治疗6个月时外阴瘙痒评分比较(分,±s)
Table 1 Comparison of vulvar pruritus scores before treatment and after 6 months of treatment in research group(score,±s)
表2 研究组治疗前与治疗结束后6个月时外阴白色病变皮肤面积的比较(cm2±s)
Table 2 Comparison of vulvar leucoplakia area calculation before treatment and after 6 months of treatment in research group(cm2±s)
表3 研究组治疗前与治疗后6个月时外阴皮肤弹性评分比较(分,±s)
Table 3 Comparison of vulvar skin elasticity before treatment and after 6 months of treatment in research group(score,±s)
表4 研究组治疗前与治疗结束后6个月时3种类型外阴病变组织及其与对照组ER,PR及survivin表达水平比较 (%)
Table 4 Comparison of expression of ER, PR and survivin in focal tissues before treatment and after 6 months of treatment by HIFM among types of SHV, SHV, LSV, LSCSH in research group and in control group (%)
1
Xiong ZA. Nonneoplasia epithelial disorders of skin and mucosa of Vulva//Yue J. Obstetrics and gynecology. 7th ed[M].Beijing:People's Medical Publishing House,2008,331-335.
2
Yin GP, He N. Curative effect of high intensity focusedultrasound for nonneoplasia epithelial disorders of skin and mucosa of vulva[J].Prog Obstet Gynecol, 2007,17(8):633-634.
3
Yin GP, Ti SM, Yang SJ,et al. Therapeutic methods and effects of high intensity focused ultrasound on the treatment of nonneoplasia epithelial disorders of skin and mucosa of vulva[J/CD]. Chin J Obstet Gynecol Pediatr:Electron Ed,2010,6(4):265-269.
4
Yin GP, Li J, Zhu TY,et al. Expression of survivin, estrogen receptor and progesterone receptor of endometrium of patients with anovulatory dysfunctional uterine bleeding before and after radiofequency heat-coaglulation treantmen[J/CD]. Chin J Obstet Gynecol Pediatr: Electron Ed,2010,6(3):175-181.
5
Garau JM, Di Paola GH. Estrogen and progesterone receptor assays on the vulvar epithelium[J]. J Peprod Med,1986, 31(10):987-991.
6
Liu HM, Xie J, Li ZH. Progress of treatment for nonneoplasia epithelial disorders of skin and mucosa of vulva[J].J Military Surg Southwest China, 2008,10(6):20-23.
7
Jiao NX, Hu LN, Xiong ZA, et al. Clinical curative effect study in treatment of 900 patients with intraepithelial non-tumor-like lesion of vulvae with focused ultrasound[J].Chin J Obstet Gynecol, 2007, 42(1):7-8.
8
Liu YH, Lin SY, Guo SQ, et al. Theory and application of high intensity focused ultrasound[J]. Progr Modern Biomed,2008, 8(7):1344-1345.
9
Nagai MA, Brentani MM. Gene expression profiles in breast cancer to identify estrogen receptor target genes[J]. Mini Rev Med Chem,2008, 8(5): 448-454.
10
Ogle TF. Progesterone-action in the decidual mesometrium of pregnancy[J].Steroids, 2002, 67(1):1-14.
11
Weikert S, Schrader M, Krause H, et al. The inhibitor of apoptosis (IAP) survivin is expressed in human testiculas qerm cell tumor and normal testes[J]. Cancer Lett, 2005, 223(2):331-337.
[1] 张潇尹, 于洋. 牙龈卟啉单胞菌介导慢性肾病发生发展的研究进展[J]. 中华口腔医学研究杂志(电子版), 2023, 17(05): 328-334.
[2] 张华, 孙宇, 乡世健, 李樱媚, 王小群. 循环肿瘤细胞预测晚期胃肠癌患者化疗药物敏感性的研究[J]. 中华普通外科学文献(电子版), 2023, 17(06): 422-425.
[3] 莫波, 王佩, 王恒, 何志军, 梁俊, 郝志楠. 腹腔镜胃癌根治术与改良胃癌根治术治疗早期胃癌的疗效[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 644-647.
[4] 索郎多杰, 高红桥, 巴桑顿珠, 仁桑. 腹腔镜下不同术式治疗肝囊型包虫病的临床疗效分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 670-673.
[5] 唐浩, 梁平, 徐小江, 曾凯, 文拨辉. 三维重建指导下腹腔镜右半肝加尾状叶切除治疗Bismuth Ⅲa型肝门部胆管癌的临床研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 688-692.
[6] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[7] 邰清亮, 施波, 侍新宇, 陈国梁, 陈俊杰, 武冠廷, 王索, 孙金兵, 顾闻, 叶建新, 何宋兵. 腹腔镜次全结肠切除术治疗顽固性慢传输型便秘的疗效分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 478-483.
[8] 徐红莉, 杨钰琳, 薛清, 张茜, 马丽虹, 邱振刚. 体外冲击波治疗非特异性腰痛疗效的系统评价和Meta分析[J]. 中华老年骨科与康复电子杂志, 2023, 09(05): 307-314.
[9] 姜里蛟, 张峰, 周玉萍. 多学科诊疗模式救治老年急性非静脉曲张性上消化道大出血患者的临床观察[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 520-524.
[10] 梁文龙, 曹杰, 黄庆, 林泳, 黄红丽, 杨平, 李冠炜, 胡鹤. 信迪利单抗联合瑞戈非尼治疗晚期结直肠癌的疗效与安全性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 409-413.
[11] 高显奎, 赵太云, 陆兴俊, 张洪领, 房修罗, 闫碧春, 王胤, 王永翠, 刘苗苗, 冉若男. 内镜电凝止血与组织胶注射治疗上消化道溃疡伴出血的疗效观察[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 452-455.
[12] 张景旭, 李德舫, 由上可, 张玉田. 贝伐珠单抗与安罗替尼联合奥沙利铂治疗晚期直肠癌的临床疗效[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 289-293.
[13] 杨镠, 秦岚群, 耿茜, 李栋庆, 戚春建, 蒋华. 可溶性免疫检查点对胃癌患者免疫治疗疗效和预后的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 305-311.
[14] 盛静, 梅勇, 夏佩, 王晓林. 乌苯美司联合伊立替康二线治疗晚期胃癌的临床研究[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 317-321.
[15] 李莹倩, 李华山. 基于真实世界的完全性直肠脱垂治疗方式评价[J]. 中华临床医师杂志(电子版), 2023, 17(06): 700-705.
阅读次数
全文


摘要